Cargando…
PARP10 is highly expressed and associated with inferior outcomes in acute myeloid leukemia
Acute myeloid leukemia is a heterogeneous disease of the hematopoietic system, which possesses a poor prognosis; thus, the identification of novel molecular markers is urgently needed to better define the risk stratification and optimize treatment therapies for this disease. Here, we investigated th...
Autores principales: | Wang, Ling, Jiang, Chuang, Hu, Dandan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415541/ https://www.ncbi.nlm.nih.gov/pubmed/37506247 http://dx.doi.org/10.18632/aging.204832 |
Ejemplares similares
-
Different regulation of PARP1, PARP2, PARP3 and TRPM2 genes expression in acute myeloid leukemia cells
por: Gil-Kulik, Paulina, et al.
Publicado: (2020) -
Lysyl oxidase expression is associated with inferior outcome and Extramedullary disease of acute myeloid leukemia
por: Kunadt, Desiree, et al.
Publicado: (2020) -
Reduced expression of chemerin is associated with poor clinical outcome in acute myeloid leukemia
por: Zhang, Jing, et al.
Publicado: (2017) -
Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia
por: Wang, Jie, et al.
Publicado: (2021) -
High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects
por: Li, Xia, et al.
Publicado: (2018)